152 related articles for article (PubMed ID: 35610285)
1. Lab-on-chip assay of tumour markers and human papilloma virus for cervical cancer detection at the point-of-care.
Wormald BW; Moser N; deSouza NM; Mantikas KT; Malpartida-Cardenas K; Pennisi I; Ind TEJ; Vroobel K; Kalofonou M; Rodriguez-Manzano J; Georgiou P
Sci Rep; 2022 May; 12(1):8750. PubMed ID: 35610285
[TBL] [Abstract][Full Text] [Related]
2. Use of hTERT and HPV E6/E7 mRNA RT-qPCR TaqMan assays in combination for diagnosing high-grade cervical lesions and malignant tumors.
Wang HY; Park S; Kim S; Lee D; Kim G; Kim Y; Park KH; Lee H
Am J Clin Pathol; 2015 Mar; 143(3):344-51. PubMed ID: 25696792
[TBL] [Abstract][Full Text] [Related]
3. The role of human telomerase catalytic subunit mRNA expression in cervical dysplasias.
Tsezou A; Oikonomou P; Kollia P; Mademtzis I; Kostopoulou E; Messinis I; Vamvakopoulos N
Exp Biol Med (Maywood); 2005 Apr; 230(4):263-70. PubMed ID: 15792948
[TBL] [Abstract][Full Text] [Related]
4. Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA.
Snijders PJ; van Duin M; Walboomers JM; Steenbergen RD; Risse EK; Helmerhorst TJ; Verheijen RH; Meijer CJ
Cancer Res; 1998 Sep; 58(17):3812-8. PubMed ID: 9731489
[TBL] [Abstract][Full Text] [Related]
5. Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer.
Kailash U; Soundararajan CC; Lakshmy R; Arora R; Vivekanandhan S; Das BC
Br J Cancer; 2006 Nov; 95(9):1250-7. PubMed ID: 17060942
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic performance of HPV E6/E7, hTERT, and Ki67 mRNA RT-qPCR assays on formalin-fixed paraffin-embedded cervical tissue specimens from women with cervical cancer.
Wang HY; Kim G; Cho H; Kim S; Lee D; Park S; Park KH; Lee H
Exp Mol Pathol; 2015 Jun; 98(3):510-6. PubMed ID: 25835783
[TBL] [Abstract][Full Text] [Related]
7. Genomic amplification of the human telomerase gene (hTERC) associated with human papillomavirus is related to the progression of uterine cervical dysplasia to invasive cancer.
Liu H; Liu S; Wang H; Xie X; Chen X; Zhang X; Zhang Y
Diagn Pathol; 2012 Oct; 7():147. PubMed ID: 23107094
[TBL] [Abstract][Full Text] [Related]
8. [Telomerase level versus spliced hTERT-specific RNA forms in cervical carcinoma].
Fedorova MD; Petrenko AA; Skvortsov DA; Pavlova LS; Zvereva ME; Rubtsova MP; Dontsova OA; Kiselev FL
Vopr Onkol; 2010; 56(1):29-35. PubMed ID: 20361612
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling to identify markers associated with deregulated hTERT in HPV-transformed keratinocytes and cervical cancer.
de Wilde J; Wilting SM; Meijer CJ; van de Wiel MA; Ylstra B; Snijders PJ; Steenbergen RD
Int J Cancer; 2008 Feb; 122(4):877-88. PubMed ID: 17960611
[TBL] [Abstract][Full Text] [Related]
10. Human telomerase reverse transcriptase regulates vascular endothelial growth factor expression via human papillomavirus oncogene E7 in HPV-18-positive cervical cancer cells.
Li F; Cui J
Med Oncol; 2015 Jul; 32(7):199. PubMed ID: 26067630
[TBL] [Abstract][Full Text] [Related]
11. HPV
Kim G; Taye J; Yu K; Park S; Kim J; Kim S; Lee D; Wang HY; Park KH; Lee H
Anal Cell Pathol (Amst); 2019; 2019():9365654. PubMed ID: 30775237
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of telomerase (hTERT) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus, virus persistence, or disease outcome in cervical cancer.
Branca M; Giorgi C; Ciotti M; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Mariani L; Ruutu M; Syrjänen S; Favalli C; Syrjänen K
Diagn Cytopathol; 2006 Nov; 34(11):739-48. PubMed ID: 17041957
[TBL] [Abstract][Full Text] [Related]
13. HPV E6/E7 mRNA versus HPV DNA biomarker in cervical cancer screening of a group of Macedonian women.
Duvlis S; Popovska-Jankovic K; Arsova ZS; Memeti S; Popeska Z; Plaseska-Karanfilska D
J Med Virol; 2015 Sep; 87(9):1578-86. PubMed ID: 25880030
[TBL] [Abstract][Full Text] [Related]
14. Human Papillomavirus E6/E7 oncogene transcripts as biomarkers for the early detection of cervical cancer.
Gupta SM; Warke H; Chaudhari H; Mavani P; Katke RD; Kerkar SC; Mania-Pramanik J
J Med Virol; 2022 Jul; 94(7):3368-3375. PubMed ID: 35257379
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Performance of HPV E6/E7 mRNA and HPV DNA Assays for the Detection and Screening of Oncogenic Human Papillomavirus Infection among Woman with Cervical Lesions in China.
Wang HY; Lee D; Park S; Kim G; Kim S; Han L; Yubo R; Li Y; Park KH; Lee H
Asian Pac J Cancer Prev; 2015; 16(17):7633-40. PubMed ID: 26625774
[TBL] [Abstract][Full Text] [Related]
16. Point-of-care HPV DNA testing of self-collected specimens and same-day thermal ablation for the early detection and treatment of cervical pre-cancer in women in Papua New Guinea: a prospective, single-arm intervention trial (HPV-STAT).
Vallely AJB; Saville M; Badman SG; Gabuzzi J; Bolnga J; Mola GDL; Kuk J; Wai M; Munnull G; Garland SM; Brotherton JML; Kelly-Hanku A; Morgan C; Toliman PJ; Kombati Z; Kariwiga G; Babona D; Tan G; Simms KT; Cornall AM; Tabrizi SN; Wand H; Guy R; Canfell K; Kaldor JM
Lancet Glob Health; 2022 Sep; 10(9):e1336-e1346. PubMed ID: 35878625
[TBL] [Abstract][Full Text] [Related]
17. Cervical intraepithelial neoplasia: Telomerase activity and splice pattern of hTERT mRNA.
Petrenko AA; Korolenkova LI; Skvortsov DA; Fedorova MD; Skoblov MU; Baranova AV; Zvereva ME; Rubtsova MP; Kisseljov FL
Biochimie; 2010 Dec; 92(12):1827-31. PubMed ID: 20691751
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of the E6/E7 mRNA-based Optimygene HR-HPV RT-qDx assay for cervical cancer screening.
Wang HY; Kim H; Park KH
Int J Infect Dis; 2019 Jan; 78():22-30. PubMed ID: 30248464
[TBL] [Abstract][Full Text] [Related]
19. Correlation of hTERT Expression with Cervical Cytological Abnormalities and Human Papillomavirus Infection.
Zejnullahu VA; Zejnullahu VA; Josifovska S; Vukovik N; Pakovski K; Panov S
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2017 Dec; 38(3):143-151. PubMed ID: 29668478
[TBL] [Abstract][Full Text] [Related]
20. Health economic evaluation of an mRNA high-risk human papillomavirus (HR-HPV) assay versus a DNA HR-HPV assay for the proposed French cervical screening programme.
Dombrowski CA; Weston GM; Descamps PP; Izopet PJ; Adams EJ; Adams E
Medicine (Baltimore); 2022 Jul; 101(29):e29530. PubMed ID: 35866838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
